New target discovered for brain cancer treatment
Neurology News & Neuroscience News from Medical News Today
A new study is giving researchers hope that novel targeted therapies can be developed for glioblastoma multiforme (GBM), the most common and most aggressive form of brain cancer, after demonstrating for the first time that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) is a driving force behind the disease's aggressive and invasive nature.
Original Article: http://www.medicalnewstoday.com/releases/271075.php
No comments:
Post a Comment